Business Growth
We help healthcare, pharma, and biotech companies simplify complexity with strategic guidance and actionable insights.
The wrong partnership creates more complexity than value.
Strategic support across partnerships, licensing, acquisitions, commercialisation, and strategic collaborations.
Problem
Partnerships often look stronger on paper than they perform in execution.
External relationships help companies access capabilities, reduce risk, enter markets, and move faster. But many fail because the strategic and operational logic is not fully tested before commitment.
Misaligned incentives
Both sides may enter discussions with different objectives, timelines, economics, responsibilities, or levels of control. Alignment can look strong early, then break during execution.
Weak strategic fit
A strong company, product, or technology does not automatically create the right partnership. Operating models, execution needs, and commercial realities still need to align.
Poor positioning
Companies can lose opportunities when they cannot clearly explain where they fit, what they offer, and why they matter to partners, licensors, distributors, buyers, or acquirers.
Solution
Partnerships succeed when fit,
structure, and execution
are addressed early.
We help organisations evaluate opportunities, assess strategic and operational fit, structure partnerships and transactions, and position themselves more clearly before complexity compounds.
Partnership & transaction areas
Support across partnership, licensing,
manufacturing, and transaction
decisions.
Build-Buy-Partner Decisions
Determine whether capabilities should be built internally, acquired, or accessed through partnerships.
Licensing & Commercialisation
Support across licensing-in, licensing-out, commercialisation partnerships.
Manufacturing & Supply Partnerships
Evaluation of manufacturing, CDMO, supply chain, and operational partnership models.
Distribution & Market Access
Assessment of distributor relationships, regional partnerships, and commercial expansion pathways.
Acquisitions & Strategic Transactions
Support across acquisition evaluation, strategic fit assessment, and transaction structuring.
Our process
End-to-end support across
the partnership lifecycle.
Define
Clarify objectives, constraints, growth pathway & partnership priorities.
Identify
Map relevant counterparties, opportunities, manufacturers or targets.
Assess
Evaluate strategic fit, incentives, execution readiness, and commercial realities.
Structure
Support transaction logic, governance, responsibilities, and operational alignment.
Execute
Support integration, execution coordination, value realisation after agreements are in place.
Who we support
Built for companies across
different stages of growth.
Our model adapts based on company stage and transaction context.
1
Early-Stage Companies
Typical Focus
- Clarifying strategic positioning and partnership narrative
- Evaluating licensing, manufacturing, distributor, or collaboration pathways
- Assessing counterparties and relationship structures
- Preparing for strategic engagement discussions
Help early-stage companies position themselves more clearly for partnerships, commercialisation, and long-term growth.
2
Commercial Stage
Typical Focus
- Evaluating licensing, acquisition, manufacturing, distribution, and strategic partnership opportunities
- Managing both inbound and outbound strategic relationships
- Assessing strategic fit, execution readiness, and operational alignment
- Structuring partnerships and transactions to support scalable growth
Help growth-stage companies evaluate, structure, and execute strategic relationships across both buy-side and sell-side opportunities.
3
Strategics
Typical Focus
- Evaluating acquisition, partnership, and capability expansion opportunities
- Assessing strategic fit, operational integration, and execution risks
- Evaluating counterparties, ecosystems, and commercial alignment
- Structuring partnerships and transactions across larger operating environments
Support larger organisations in evaluating and executing strategic partnerships with greater operational and strategic clarity.
Therapeutic & Product Companies
- In-Vitro Diagnostics (IVD)
- Medical Devices
- Digital Health
- Biotech
Infrastructure &
Services
- Research Platforms
- Manufacturing & Supply Infrastructure
- Automation & Tooling
- CROs & CDMOs
Why Nuvantta
Built for healthcare and
life sciences partnerships.
Matched
expertise
Engagement teams are aligned to the specific product, operational challenge, and healthcare market involved.
Independent
perspective
Structured and objective support designed to identify gaps, execution risks, and strategic friction early.
Cross-functional healthcare perspective
Partnerships are evaluated across scientific, commercial, manufacturing, regulatory, and market realities.
Commercial and execution focus
The objective is not simply to complete transactions, but to structure partnerships that can realistically work in execution.
Selected examples
Examples of partnership, transaction,
and collaboration work.
Regional Commercialisation
Example engagement focused on partnership strategy, counterparty evaluation, deal structure, or value realisation.
Manufacturing & Scale-Up
Example engagement focused on partnership strategy, counterparty evaluation, deal structure, or value realisation.
Market Expansion
Example engagement focused on partnership strategy, counterparty evaluation, deal structure, or value realisation.